Why the study?
What patient factors influence warfarin dose response?
What patient factors influence warfarin dose response?
Optimization of warfarin therapy requires consideration of multiple clinical and pharmacogenetic factors that affect its pharmacokinetics and pharmacodynamics.
Answers are grounded in this paper and cite their sources.
Clinicians must integrate patient factors into warfarin dosing; confirms established influences but leaves optimization algorithms open.
Warfarin has long been the mainstay of oral anticoagulation therapy for the treatment and prevention of venous and arterial thrombosis. The narrow therapeutic index of warfarin, and the complex number of factors that influence international normalized ratio (INR) response, makes optimization of warfarin therapy challenging. Determination of the appropriate warfarin dose during initiation and maintenance therapy requires an understanding of patient factors that influence dose response: age, body weight, nutritional status, acute and chronic disease states, and changes in concomitant drug therapy and diet. This review will examine specific clinical factors that can affect the pharmacokinetics and pharmacodynamics of warfarin, as well as the role of pharmacogenetics in optimizing warfarin therapy.
No takes yet. Share an insight, caveat, or question.
Pamela J. White (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: